K31.A11

Clinical Causes: Chronic Helicobacter pylori infection, leading to persistent inflammation of the stomach lining. Long-term gastritis resulting from autoimmune diseases or chronic irritation. Prolonged use of certain medications, such as nonsteroidal anti-inflammatory drugs (NSAIDs). Dietary factors, including high salt intake or consumption of smoked and preserved foods. Smoking and alcohol consumption, which can irritate and inflame the stomach lining. Family history of gastric conditions or certain genetic factors.

Key Symptoms: Often no noticeable symptoms in the early stages. Indigestion or discomfort in the upper abdomen. Nausea or a feeling of fullness after eating. Occasional bloating or belching. Symptoms related to underlying causes, such as gastritis or infection.

Diagnosis Path: Diagnosing gastric intestinal metaplasia involves a combination of medical history review, endoscopic examination, and biopsy. During an upper endoscopy, a doctor inserts a flexible tube with a camera into the stomach to look for abnormal tissue. Tissue samples taken from the antrum are examined under a microscope to identify intestinal metaplasia. Additional tests, like blood tests or tests for H. pylori infection, may also be performed to assess underlying causes and related factors.

Treatment Protocols: While gastric intestinal metaplasia without dysplasia typically doesn't require immediate treatment, management strategies focus on addressing underlying causes and reducing the risk of progression. These include: - Eradication of H. pylori infection with antibiotics. - Use of medications to reduce stomach acid and protect the stomach lining. - Lifestyle modifications, such as quitting smoking, limiting alcohol intake, and adopting a balanced diet. - Regular monitoring through endoscopic examinations to observe any changes over time. In some cases, healthcare providers may recommend additional surveillance or interventions if further cellular changes are detected.